CEACAM5 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Products
CEA (CEACAM5) mouse monoclonal antibody, clone OTI3E10 (formerly 3E10)
| Applications | IHC, WB |
| Reactivities | Human |
Ceacam5 - KN2.0, Mouse gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
CEACAM5 (myc-DDK-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Human CEACAM5 ELISA Kit 1 x 96
| Type | Sandwich |
| Format | 8x12 divisible strips |
| Reactivity | Human |
CEACAM5 (tGFP-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Lenti-ORF clone of CEACAM5 (Myc-DDK-tagged)-Human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK |
- LentiORF®
CEACAM5 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Purified CEA (CEACAM5) mouse monoclonal antibody, clone OTI9F9 (formerly 9F9)
| Applications | WB |
| Reactivities | Human |
CEACAM5 CRISPRa kit - CRISPR gene activation of human carcinoembryonic antigen related cell adhesion molecule 5
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
qSTAR qPCR primer pairs against Homo sapiens gene CEACAM5
qPCR primer pairs and template standards against Homo sapiens gene CEACAM5
| Application | Plasmid of exact quantity for transcript copy number calculation |
Ceacam5 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
